Suchergebnisse - "Dejnirattisai, Wanwisa"

PubPharm (9)

1

Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens

enthalten in: Med (New York, N.Y.) | 2023

von Moore, S. | Kronsteiner, B. | Longet, S. | +62

2

Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules : exploratory analyses of Com-COV, a randomised control trial

enthalten in: The Lancet. Respiratory medicine | 2022

von Shaw, R. | Liu, X. | Stuart, A. | +82

3

Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK : Three month analyses of the COV-BOOST trial

enthalten in: The Journal of infection | 2022

von Liu, X. | Munro, A. | Feng, S. | +56

CommentIn: J Infect. 2023 Feb;86(2):154-225. - PMID 36509358

4

Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines

enthalten in: Nature medicine | 2022

von Wei, J. | Pouwels, K. | Stoesser, N. | +76

5

Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV

enthalten in: JCI insight | 2022

von Ogbe, A. | Pace, M. | Bittaye, M. | +55

6

The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 beta (B.1.351) and other variants of concern in preclinical studies

enthalten in: EBioMedicine | 2022

von Spencer, A. | Morris, S. | Ulaszewska, M. | +23

7

Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001) : a phase 4, non-inferiority, single blind, randomised study

enthalten in: Lancet (London, England) | 2022

von Costa Clemens, S. | Weckx, L. | Clemens, R. | +44

CommentIn: Lancet. 2022 Feb 5;399(10324):496-497. - PMID 35074137

8

Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK : a substudy of two randomised controlled trials (COV001 and COV002)

enthalten in: Lancet (London, England) | 2021

von Flaxman, A. | Marchevsky, N. | Jenkin, D. | +135

CommentIn: Lancet. 2021 Sep 11;398(10304):933-935. - PMID 34480860

9

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection : a single-arm substudy of a phase 2/3 clinical trial

enthalten in: The lancet. HIV | 2021

von Frater, J. | Ewer, K. | Ogbe, A. | +67

CommentIn: Lancet HIV. 2021 Aug;8(8):e455-e456. - PMID 34153265

1
[1]